Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function

ClinicalTrials.gov ID: NCT04119843

Public ClinicalTrials.gov record NCT04119843. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 9:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-label Study to Evaluate the Safety and Diagnostic Efficacy of Mangoral in Patients With Known or Suspected Focal Liver Lesions and Severe Renal Impairment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The overall objective of this study is to evaluate the safety and diagnostic efficacy of Mangoral in liver MRI in participants with known or suspected focal liver lesions and severe renal impairment. The diagnostic efficacy of Mangoral will be assessed in terms of visualization of detected focal liver lesions in combined MRI (CMRI: combined Mangoral-enhanced and unenhanced MRI) compared to unenhanced MRI.

Study identification

NCT ID
NCT04119843
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ascelia Pharma AB
Industry
Enrollment
87 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 19, 2020 (Actual)
Primary completion
Feb 17, 2023 (Actual)
Completion
Feb 17, 2023 (Actual)
Last update posted
Feb 6, 2025

2020 – 2023

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Mayo Clinic - Arizona Scottsdale Arizona 85259 —
University of California at Los Angeles Ronald Reagan Medical Center Los Angeles California 90095 —
Stanford University School of Medicine Stanford California 94305 —
Mayo Clinic - Jacksonville Jacksonville Florida 32224 —
Schiff Center for Liver Diseases Miami Florida 33136 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Johns Hopkins Bayview Medical Center Baltimore Maryland 21287 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Boston University Medical Center Boston Massachusetts 02118 —
Saint Louis University St Louis Missouri 63103 —
Duke University Durham North Carolina 27710 —
PanAmerican Clinical Research LLC Brownsville Texas 78521 —
University of Washington Medical Center Seattle Washington 98195 —
University of Wisconsin - Madison Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04119843, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 6, 2025 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04119843 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →